Casma Therapeutics

Casma Therapeutics

Casma Therapeutics

We're harnessing the natural process of autophagy to design powerful new medicines for a broad range of diseases.
Raised
$58.5M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$58,500,000
Venture capital (Series A) - 2018
Third Rock Ventures
Team Size
1–10
Employees
$58,500,000 Venture capital (Series A)
FinSMEs , PE HUB

Casma Therapeutics Raises $58.5M in Series A Funding

Science Health